# Hyper-CVAD Treatment in Lymphoblastic Lymphoma

> **NCT01813344** · — · UNKNOWN · sponsor: **Ajou University School of Medicine** · enrollment: 50 (estimated)

## Conditions studied

- Lymphoblastic Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01813344
- **Lead sponsor:** Ajou University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2013-06
- **Final completion:** —
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01813344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01813344, "Hyper-CVAD Treatment in Lymphoblastic Lymphoma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01813344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*